BR112012023317A2 - hidrato de cloridrato de agomelatina e sua preparação - Google Patents

hidrato de cloridrato de agomelatina e sua preparação

Info

Publication number
BR112012023317A2
BR112012023317A2 BR112012023317A BR112012023317A BR112012023317A2 BR 112012023317 A2 BR112012023317 A2 BR 112012023317A2 BR 112012023317 A BR112012023317 A BR 112012023317A BR 112012023317 A BR112012023317 A BR 112012023317A BR 112012023317 A2 BR112012023317 A2 BR 112012023317A2
Authority
BR
Brazil
Prior art keywords
preparation
hydrochloride hydrate
agomelatine hydrochloride
agomelatine
hydrate
Prior art date
Application number
BR112012023317A
Other languages
English (en)
Other versions
BR112012023317B1 (pt
Inventor
Hanbin Shan
Hongjuan Pan
Peng Zhang
Xiong Yu
Xueyan Zhu
Zhedong Yuan
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44599556&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012023317(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of BR112012023317A2 publication Critical patent/BR112012023317A2/pt
Publication of BR112012023317B1 publication Critical patent/BR112012023317B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Abstract

hidrato de cloridrato de agomelatina e sua preparação. a presente invenção refere-se a um hidrato de cloridrato de agomelatina de fórmula (i), a preparação, o uso, e a composição farmacêutico do mesmo. o dito hidrato obtido através do presente método tem solubilidade aumentanda significativa do que a agometatina, e, portanto, é mais adequado para a fabricação de formulações farmacêuticas. usando o presente método, uma alta pureza pode ser obtida através de um processo simples, livre de quaisquer etapas complicadas. onde x é ci.
BR112012023317-3A 2010-03-17 2011-03-17 hidrato de cloridrato de agomelatina e sua preparação BR112012023317B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010126254.X 2010-03-17
CN201010126254XA CN102190594A (zh) 2010-03-17 2010-03-17 阿戈美拉汀氯化氢水合物及其制备方法
PCT/CN2011/071910 WO2011113362A1 (en) 2010-03-17 2011-03-17 Agomelatine hydrochloride hydrate and preparation thereof

Publications (2)

Publication Number Publication Date
BR112012023317A2 true BR112012023317A2 (pt) 2016-05-24
BR112012023317B1 BR112012023317B1 (pt) 2021-07-06

Family

ID=44599556

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012023317-3A BR112012023317B1 (pt) 2010-03-17 2011-03-17 hidrato de cloridrato de agomelatina e sua preparação

Country Status (36)

Country Link
US (1) US8729131B2 (pt)
EP (1) EP2547649B1 (pt)
JP (1) JP5634532B2 (pt)
KR (1) KR101406727B1 (pt)
CN (2) CN102190594A (pt)
AP (1) AP2012006492A0 (pt)
AU (1) AU2011229618B2 (pt)
BR (1) BR112012023317B1 (pt)
CA (1) CA2792417C (pt)
CL (1) CL2012002540A1 (pt)
CR (1) CR20120462A (pt)
CU (1) CU20120137A7 (pt)
CY (1) CY1116086T1 (pt)
DK (1) DK2547649T3 (pt)
EA (1) EA022067B1 (pt)
EC (1) ECSP12012155A (pt)
ES (1) ES2530772T3 (pt)
GE (1) GEP20156231B (pt)
GT (1) GT201200259A (pt)
HK (1) HK1177451A1 (pt)
HR (1) HRP20150071T1 (pt)
IL (1) IL221782A (pt)
MA (1) MA34055B1 (pt)
ME (1) ME02054B (pt)
MX (1) MX2012010541A (pt)
NI (1) NI201200140A (pt)
NZ (1) NZ602450A (pt)
PE (1) PE20130013A1 (pt)
PL (1) PL2547649T3 (pt)
PT (1) PT2547649E (pt)
RS (1) RS53815B1 (pt)
SG (1) SG183868A1 (pt)
SI (1) SI2547649T1 (pt)
TN (1) TN2012000435A1 (pt)
UA (1) UA105425C2 (pt)
WO (1) WO2011113362A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2551257A1 (en) * 2011-07-28 2013-01-30 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of agomelatine with co-crystal-formers
FR2978916B1 (fr) 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
CN102702041B (zh) * 2012-05-14 2013-08-14 上海右手医药科技开发有限公司 阿戈美拉汀苯磺酸类复合物及其制备方法
KR20150020191A (ko) * 2012-05-14 2015-02-25 상하이 라이트핸드 팜테크 주식회사 아고멜라틴 산기 복합체와 그의 제조방법 및 용도
CN102718675B (zh) * 2012-06-07 2015-03-25 上海右手医药科技开发有限公司 阿戈美拉汀甲磺酸复合物及其制备方法
CN102718676B (zh) * 2012-06-26 2014-04-09 福建广生堂药业股份有限公司 阿戈美拉汀硫酸盐及其制备方法
WO2014096373A1 (en) 2012-12-21 2014-06-26 Laboratorios Lesvi, S. L. Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2015013865A1 (en) * 2013-07-29 2015-02-05 Les Laboratoires Servier Agomelatine sulfonic acids complexes and preparation thereof
KR101470794B1 (ko) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 아고멜라틴 공결정의 제조 방법 및 이를 포함하는 조성물
EP3317281B1 (en) 2015-07-02 2020-04-22 Acerta Pharma B.V. Solid forms and formulations of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
US10367757B2 (en) * 2016-08-27 2019-07-30 Nicira, Inc. Extension of network control system into public cloud

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
SK6182003A3 (en) * 2000-10-30 2004-03-02 Teva Pharma Crystalline and solvated forms of ondansetrone hydrochloride and preparation thereof
FR2890562B1 (fr) * 2005-09-09 2012-10-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime
FR2899472B1 (fr) * 2006-04-07 2008-09-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee
FR2934859B1 (fr) 2008-08-05 2010-08-13 Servier Lab Nouveau procede de synthese de l'agomelatine
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms

Also Published As

Publication number Publication date
CA2792417C (en) 2015-11-24
BR112012023317B1 (pt) 2021-07-06
NZ602450A (en) 2014-12-24
KR20120128712A (ko) 2012-11-27
EA022067B1 (ru) 2015-10-30
ME02054B (me) 2015-05-20
GEP20156231B (en) 2015-01-26
US20130005820A1 (en) 2013-01-03
JP2013522241A (ja) 2013-06-13
US8729131B2 (en) 2014-05-20
NI201200140A (es) 2012-11-09
CL2012002540A1 (es) 2013-01-11
UA105425C2 (ru) 2014-05-12
EA201201294A1 (ru) 2013-04-30
IL221782A (en) 2017-11-30
EP2547649B1 (en) 2014-11-19
JP5634532B2 (ja) 2014-12-03
HRP20150071T1 (en) 2015-02-27
PL2547649T3 (pl) 2015-04-30
KR101406727B1 (ko) 2014-06-13
ECSP12012155A (es) 2012-12-28
CN102958911B (zh) 2015-11-25
RS53815B1 (en) 2015-06-30
AP2012006492A0 (en) 2012-10-31
GT201200259A (es) 2013-12-03
SI2547649T1 (sl) 2015-03-31
MA34055B1 (fr) 2013-03-05
DK2547649T3 (en) 2015-03-02
PE20130013A1 (es) 2013-01-26
CN102190594A (zh) 2011-09-21
EP2547649A4 (en) 2013-09-04
CN102958911A (zh) 2013-03-06
MX2012010541A (es) 2012-10-05
CY1116086T1 (el) 2017-02-08
CA2792417A1 (en) 2011-09-22
TN2012000435A1 (en) 2014-01-30
AU2011229618B2 (en) 2014-05-22
AU2011229618A1 (en) 2012-09-27
ES2530772T3 (es) 2015-03-05
PT2547649E (pt) 2014-12-29
HK1177451A1 (zh) 2013-08-23
EP2547649A1 (en) 2013-01-23
WO2011113362A1 (en) 2011-09-22
SG183868A1 (en) 2012-10-30
CR20120462A (es) 2012-10-05
CU20120137A7 (es) 2012-11-15

Similar Documents

Publication Publication Date Title
BR112012023317A2 (pt) hidrato de cloridrato de agomelatina e sua preparação
BR112013020513A2 (pt) adoçante stevia altamente solúvel
BR112015005891A2 (pt) método de sintetizar análogos do hormônio da tireoide e polimorfos destes
DOP2014000204A (es) Compuestos de heterociclilo como inhibidores de mek
NZ739760A (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
MY160460A (en) Agomelatine hydrochloride hydrate and preparation thereof
CR20120287A (es) Nuevos co-cristales de agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112014018756A8 (pt) Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico
EA201501122A8 (ru) Новые агонисты соматостатиновых рецепторов подтипа 4 (sstr4)
CO6420335A2 (es) Un complejo de haluro de hidrogeno de agomelatina y la preparación del mismo
BR112015031913A2 (pt) processo para a fabricação de amino-benzoxazinonas 4-propargilatadas e sua utilização
BR112014013098A2 (pt) composições compreendendo ácidos graxos que têm 20 carbonos e métodos de produção e uso dos mesmos
BR112013007687A2 (pt) pó de metal de lítio puro, estabilizado e processo para a sua produção
CU24360B1 (es) Derivados de ácido heteroaril butanoico como inhibidores de lta4h
UA111357C2 (uk) Аналоги епоксіейкозатриєнової кислоти, композиція на їх основі, застосування для лікування захворювань та спосіб зниження гіпертонії та нефротоксичності (варіанти)
BR112013004925A2 (pt) derivados de éster de fosfonato e métodos de síntese deles.
BR112012017691A2 (pt) nova composição
BRPI0814115B8 (pt) composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto
BR112019001035A2 (pt) beenato de rotigotina, e método de preparação e uso do mesmo
BR112012023173A2 (pt) hidrato de bromidrato de agomelatina e preparação do mesmo
BR112017019918A2 (pt) preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica
UA112407C2 (uk) Співкристали агомелатіну, спосіб їх виготовлення і фармацевтичні композиції, що їх містять
BRPI0702817A (pt) compostos de naftaleno, processo para sua preparação e composições farmacêuticas que contêm esses compostos
NZ706070A (en) Crystalline phase of (3s.3s’) 4,4’-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine
CO6551663A2 (es) Hodrato del hidrocloruro de agomelatina y preparacion de este

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/03/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.